Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

Pneumothorax-I

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Obesity suppresses neutrophil-dependent itaconate signaling promoting ferroptosis in acute pancreatitis.

Redox biology·2026

Same author

NRF2 as a guardian of health: from an ancient survival pathway to a modern therapeutic target.

Redox biology·2026

Same author

MASLD Management in Spain: A Nationwide Survey of Gastroenterologists Highlighting Gaps in Risk Assessment and Primary Care Coordination.

Journal of clinical medicine·2026

Same author

Therapeutic potential of isothiocyanates by targeting the NRF2 pathway.

Free radical biology & medicine·2026

Same author

Hexaraphane as a potential therapeutic strategy for tauopathies.

Redox biology·2026

Same author

Modulation of the Receptor Tyrosine Kinase TIE2/<i>Tek</i> Pathway by NRF2 Activation in Neurovascular Endothelial Cells.

International journal of molecular sciences·2026

Same journal

ENDOSCOPIC REMOVAL OF BONE FOREIGN BODY EMBEDDED IN THE COLON.

Gastroenterologia y hepatologia·2026

Same journal

An uncommon endoscopic finding: esophageal intramural pseudodiverticulosis.

Gastroenterologia y hepatologia·2026

Same journal

Anemia and Hypoalbuminemia are Associated with Hepatic Encephalopathy and Mortality after Portal Hypertension-Related Bleeding.

Gastroenterologia y hepatologia·2026

Same journal

Optimization of a mobile application for the management of hepatitis D based on patient experience: an observational study in a hepatology cohort.

Gastroenterologia y hepatologia·2026

Same journal

Assessment of Training in Pancreatology and Biliary Diseases During Gastroenterology Residency: A National Survey by AEG-AESPANC.

Gastroenterologia y hepatologia·2026

Same journal

HEPATOCELLULAR CARCINOMA SURVEILLANCE: A PRACTICAL GUIDEBASED ON CURRENT EVIDENCE.

Gastroenterologia y hepatologia·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 15, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

[Heptopulmonary syndrome].

Antonio Cuadrado¹, Ainhoa Díaz², Paula Iruzubieta¹

¹Servicio de Aparato Digestivo, Hospital Universitario Marqués de Valdecilla, Santander, España.

Gastroenterologia Y Hepatologia

|April 5, 2015

Summary

This summary is machine-generated.

Hepatopulmonary syndrome involves liver disease, dilated pulmonary vessels, and low oxygen levels. Diagnosis uses contrast echocardiography; liver transplant is the only definitive treatment for this condition.

Keywords:

Cirrhosis Cirrosis Contrast enhancement echocardiography Ecocardiografía con realce de contraste de salino HPS Hepatopulmonary syndrome Hipoxemia Hypoxemia Liver transplantation SHP Síndrome hepatopulmonar Trasplante hepático

More Related Videos

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

Published on: November 29, 2018

Related Experiment Videos

Last Updated: Apr 15, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

Published on: November 29, 2018

Area of Science:

Medicine
Cardiology
Pulmonology

Background:

Hepatopulmonary syndrome (HPS) links liver disease with respiratory issues.
It presents as liver disease, pulmonary vascular dilatations, and hypoxemia.
HPS can occur with various liver conditions, not exclusively cirrhosis or portal hypertension.

Purpose of the Study:

To review the etiology, pathophysiology, clinical presentation, and treatment of hepatopulmonary syndrome.
To highlight diagnostic methods and management strategies for HPS.

Main Methods:

Review of existing literature on hepatopulmonary syndrome.
Focus on diagnostic criteria and therapeutic interventions.
Emphasis on contrast enhancement echocardiography as the gold standard.

Main Results:

Pulmonary vascular dilatations are key features, stemming from microvasculature changes.
These changes cause ventilation/perfusion mismatch and intrapulmonary shunts, leading to hypoxemia.
HPS significantly impacts patient prognosis and quality of life.

Conclusions:

Hepatopulmonary syndrome requires accurate diagnosis for timely intervention.
Liver transplantation remains the sole curative treatment for HPS.
Understanding HPS pathophysiology is crucial for managing patients with liver disease.